Evaluation of cardiac ultrasonography in the evaluation of congestive heart failure in peripartum cardiomyopathy patients treated with L-carnitine
10.3969/j.issn.1005-1678.2017.03.094
- VernacularTitle:心脏超声在左卡尼汀治疗围产期心肌病心力衰竭患者中的评估价值
- Author:
Meihua FAN
- Keywords:
cardiac ultrasound;
L-carnitine;
peripartum cardiomyopathy;
heart failure;
evaluation
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(3):301-303
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the value of echocardiography in the evaluation of congestive heart failure (PHC) in peripartum cardiomyopathy patients.Methods 64 patients with congestive heart failure were randomly divided into two groups.The control group were treated with routine therapy.The study group were treated with levocarnitine in combination with routine therapy.Echocardiography was performed before and after treatment, and the changes of each index were compared.Results There was no significant difference in left ventricular end diastolic diameter, left ventricular ejection fraction and cardiac output between the two groups before treatment.After treatment, the left ventricular end diastolic diameter, left ventricular ejection fraction and cardiac output in study group after treatment were higher than those in control group(P<0.05).There was no significant difference in left ventricular short axis shortening, left ventricular end-systolic diameter and stroke volume between the two groups before treatment, but the left ventricular short axis shortening and stroke volume in study group after treatment were higher than those in control group (P<0.05), the left ventricular end-systolic diameter was lower ethan that in control group ( P<0.05 ) .The treatment effect of the study group was significantly higher than that in control group (P<0.05).The adverse reactions was significantly lower than that in the control group (P<0.05).Conclusion L-carnitine is effective in the treatment of heart failure in peripartum cardiomyopathy patients.It can be used to evaluate the therapeutic effect of cardiac ultrasound in order to provide guidance for clinical treatment.